VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by Realityck1on Mar 03, 2017 10:16am

88 Views

Post# 25926258

RE:RE:RE:will be over .8

This is the real deal when it comes to technology. Instead of going for an MRI at 3am and having a 30 to 90 minute procedure, its been said this test would be closer to 10min. Right now the traders are having their fun - but long term this is a huge deal for patients and doctors and imo long term shareholders. Patience should ne rewarded.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario